BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27711210)

  • 1. Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice.
    Hosono K; Isonaka R; Kawakami T; Narumiya S; Majima M
    PLoS One; 2016; 11(10):e0162532. PubMed ID: 27711210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
    Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis.
    Kubo H; Hosono K; Suzuki T; Ogawa Y; Kato H; Kamata H; Ito Y; Amano H; Kato T; Sakagami H; Hayashi I; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biomed Pharmacother; 2010 Feb; 64(2):101-6. PubMed ID: 20034758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
    Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML
    Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
    Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis.
    Hosono K; Kojo K; Narumiya S; Majima M; Ito Y
    Biomed Pharmacother; 2020 Aug; 128():110264. PubMed ID: 32447215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.
    Zhang MZ; Yao B; Wang Y; Yang S; Wang S; Fan X; Harris RC
    J Clin Invest; 2015 Nov; 125(11):4281-94. PubMed ID: 26485285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis.
    Kamoshita E; Ikeda Y; Fujita M; Amano H; Oikawa A; Suzuki T; Ogawa Y; Yamashina S; Azuma S; Narumiya S; Unno N; Majima M
    Am J Pathol; 2006 Oct; 169(4):1458-72. PubMed ID: 17003499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1β by Recruited Macrophages.
    Okizaki S; Ito Y; Hosono K; Oba K; Ohkubo H; Kojo K; Nishizawa N; Shibuya M; Shichiri M; Majima M
    Am J Pathol; 2016 Jun; 186(6):1481-98. PubMed ID: 27085138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
    Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.
    Chan PC; Hsiao FC; Chang HM; Wabitsch M; Hsieh PS
    FASEB J; 2016 Jun; 30(6):2282-97. PubMed ID: 26932930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus.
    Oba K; Hosono K; Amano H; Okizaki S; Ito Y; Shichiri M; Majima M
    Biomed Pharmacother; 2014 Oct; 68(8):1125-33. PubMed ID: 25465154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.